Menopause is a normal aging phenomenon in women and consists of the gradual transition from the reproductive to the non-reproductive phase of life. The median age at the menopause is currently around 50 years. As a result of the increasing life expectancy in the first and second worlds, many women will be postmenopausal for over one-third of their lives. The influence of menopause per se on blood pressure remains
Introduction
The climacteric is a normal aging phenomenon in women and consists of the gradual transition from the reproductive to the non-reproductive phase of life. Menopause is usually defined as the cessation of menstruation or as the last menstrual period and marks the end of ovulation. Ovarian failure following menopause is characterised by oestrogen deficiency. Oestrogens exert a protective effect on the cardiovascular system, for instance, by increasing the ratio of high-density to low-density lipoproteins in plasma or by inhibiting vasomotion and thrombosis. This article reviews the epidemiology of menopause and its alleged association with hypertension. A detailed account of the reviewed studies, including a full reference list, has been published elsewhere. 1 
Menopause
There is a striking concordance in the literature that in Western industrialised societies the median age at the menopause is currently around 50 years. [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] In non-Caucasian women, however, menopause seems to occur earlier. American and South African black women have an earlier menopause than their white counterparts. Moreover, malnutrition and low body weight are associated with precocious menopause.
The most important factor determining a woman's age at the menopause is the number of ovarian follicles. 12 Human primordial germ cells separate from the somatic cells at an early stage of embryogenesis. Some 1000 to 2000 migrate to the gonadal ridge, where they rapidly multiply up to 5 to 7 million folCorrespondence: Dr Jan A Staessen, Klinisch Laboratorium Hypertensie, Inwendige Geneeskunde-Cardiologie, U.Z. Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium uncertain. Recent experimental and epidemiological evidence supports the hypothesis that oestrogen deficiency may induce endothelial and vascular dysfunction and potentiate the age-related increase in systolic pressure, possibly as a consequence of a reduced compliance of the large arteries. However, the latter hypothesis requires further investigation.
licles around the 5th month of intra-uterine life. Thereafter, multiplication ceases and the primordial follicles commence to dissolve, so that at birth both fetal ovaries combined contain no more than about 2 million follicles. This number continues to fall after birth. Fewer than 0.02% of the follicles present at birth are ovulated during the reproductive phase of life, while the remainder degenerates. In the immediate premenopausal period, the rate of loss of primordial follicles accelerates, and menopause intervenes when the number of follicles has fallen below a critical number. 13, 14 Nulliparous women tend to have an earlier menopause, 3, 15 while increased parity, particularly in the higher social classes, is associated with a later menopause. 7, 16 Mothers of twins enter the menopause about 1 year earlier than women who have only had singleton infants. 16 Women whose last pregnancy occurred before the age of 28 probably have an earlier menopause than those with their last pregnancy at a later age. 17 Women who smoke enter the menopause up to 2 years earlier than those who do not. [18] [19] [20] The effect of smoking on menopausal age seems to be dose-related and may be mediated in part via a lowered oestrogen production [21] [22] [23] [24] and/or via the toxic substances in tobacco smoke, which may contribute to the premature destruction of the primordial oocytes. 25 By the year 2025, 23% of the population will be aged 60 or over. As a result of the increasing life expectancy in the first and second worlds, many women will be postmenopausal for over one-third of their lives. 26 Already now, approximately 95% of all women living in industrialised countries experience menopause during their life-time. 27 These numbers help to explain why over the past decades menopause has grown from a subject that was peripheral to medical interest into one which takes a central place in clinical practice.
Hypertension
Systolic pressure increases with age at least until the 8th decade of life, whereas diastolic pressure rises only until 50 years of age. 28 Following middle-age, both systolic (SBP) and diastolic blood pressure (DBP) become higher in women than in men, whereas the reverse is true in the first half of life. This observation suggests that ovarian failure and the ensuing oestrogen deficiency may influence the age-related increase in BP in women. However, the BP changes associated with menopause are difficult to evaluate, because menopause coincides with aging, and because both menopause and BP are influenced by common factors, such as body mass index, socio-economic class and smoking.
Taylor et al 29 were among the first to contrast the prevalence of hypertension in menopausal women and office workers. They found that hypertension was no more prevalent among a group of 179 castrated women and 21 women with natural menopause than in control subjects and that 'vasomotor instability', as exhibited by hot flushes, perspiration and tachycardia, was not necessarily associated with hypertension. The conclusion from this pioneering study 29 was that the relationship between hypertension and menopause was incidental and that the loss of ovarian secretion was neither a primary nor a contributory cause of arterial hypertension.
Population studies in Belgium
In Belgium, the association between menopause and systolic and diastolic BP was explored in a random sample of 278 pre-and 184 postmenopausal women, who were from 35 to 59 years old. 30 All women were participants in a cross-sectional population survey with a sample size of 3950 eligible persons, of whom 67% took part. All women were characterised by the average of 10 BP readings, ie, five consecutive readings in the sitting position obtained at each of two separate home visits. The postmenopausal women had higher systolic (132 vs 121 mm Hg), diastolic (81 vs 75 mm Hg) and pulse (51 vs 46 mm Hg) pressures than the premenopausal subjects (Figure 1 ). Hypertension was more frequently observed following menopause (40 vs 10%; P Ͻ 0.001). After stratification by age and body mass index, the odds of having hypertension in premenopausal as compared with postmenopausal women were 2.2 (95% confidence interval [CI]: 1.1 to 4.4; P = 0.03). After adjustment of BP for significant covariates, such as body mass index, pulse rate and the intake of oestrogens and/or progestogens, the slope of SBP on age was 0.5 mm Hg per year steeper in the post-than in the premenopausal women. The relation of DBP with age had the same slope among pre-and postmenopausal subjects, but in postmenopausal women the regression line was shifted upward by 2.3 mm Hg (P = 0.03).
A further prospective cohort study in Belgium included 315 women (30-70 years at follow-up), who were randomly selected from the population. 31 They were matched on age and rank of body mass index with 315 men. Five BP readings were obtained by conventional sphygmomanometry at the subjects' homes on each of two baseline visits and at one follow-up visit. The 24-h ambulatory BP was recorded at follow-up. Menstrual status was assessed by ques- tionnaire. The statistical tests were two-sided and accounted for age, body mass index, anti-hypertensive treatment, contraceptive pill intake or changes in these variables. From baseline to follow-up (median, 5.2 years), 166 and 105 women stayed preor postmenopausal, while menses ceased in 44 perimenopausal women. In cross-sectional analyses, the postmenopausal women, compared with their pre-and perimenopausal counterparts, had a 4 -5 mm Hg higher conventional (15 readings per subject) and 24-h SBP (P р 0.05 for differences between peri-and postmenopausal women). Furthermore, the longitudinal results showed that SBP on conventional measurement did not change in women who stayed premenopausal throughout follow-up (P = 0.71), but increased by approximately 4 mm Hg over 5 years in peri-(P = 0.07) and postmenopausal (P = 0.01) subjects (P = 0.02 for difference between pre-and postmenopausal women). Such trends were not observed for DBP in women or for systolic or diastolic BP in men.
Other epidemiological studies
Several other cross-sectional 30,32-36 and longitudinal 31, [37] [38] [39] [40] [41] studies have addressed the putative association between hypertension and menopause (Table 1) . On balance, the longitudinal surveys suggest that menopause per se is not associated with an increase in BP or a greater incidence of hypertension. The results from the cross-sectional studies are more equivocal, as some surveys have found a positive association and other studies no relation.
Although longitudinal studies are often considered to be superior to cross-sectional surveys, both are open to confounding. Cross-sectional designs may preclude the accurate assessment of changes over time, which are due to differences in growth or development across generations (cohort differences). Longitudinal surveys, on the other hand, are easily confounded by effects related to the time of measurement. Changes in the environmental conditions inevitably occur over a given period of follow-up, and may lead to an over-or under-estimation of the true intra-individual changes and relationships over time. In particular, clinical, biochemical and technical measurements may be unduly influenced by the unavoidable renewal of chemicals, standards, and instrumentation, or changes in the team of observers. Thus, both crosssectional and longitudinal observational studies have their limitations.
Plausible pathophysiological mechanisms
Reports on oestrogen substitution therapy after menopause have convincingly demonstrated that correction of the postmenopausal oestrogen deficiency is accompanied by a decrease in the incidence of cardiovascular complications. One is therefore left with the possibility that the rise in SBP following menopause, 30 ,31 a major cardiovascular risk factor, 28 may at least in part be due to menopause per se.
Several possible mechanisms come to mind to explain the alleged increase in BP following menopause. Menopause is accompanied by weight gain 30, 31, 36, 38, 42, 43 and a rise in the circulating insulin levels. The postmenopausal oestrogen deficiency may affect the balance between various vaso-active hormones and the proliferation and function of vascular smooth muscle cells, possibly by altering the electrolyte composition of the intra-and/or extracellular milieu. Menopause through a redistribution of body sodium and the cessation of periods is followed by a rise in haemoglobin and in erythrocyte count, 37 thereby increasing blood viscosity, and in turn possibly also BP. 44, 45 In the Belgian longitudinal study 31 the specific pressor effect of menopause was confined to SBP. Thus, a reduction of arterial compliance may be involved. 46 Indeed, oestrogens dilate the large arteries in laboratory animals. 47, 48 In women, whose periods have ceased for 6 months to 5 years, the pulsatility index of the internal carotid artery was inversely correlated with the time elapsed since the last menstrual bleeding. 49 Oestrogen replacement therapy normalised their raised pulsatility index. 49 In a more recent randomised experiment with a double-blind design, 50 8 weeks of oestrogen substitution in peri- Table 1 The association between menopause and blood pressure in various studies Groups considered in the analysis: C = castrated women (bilateral oophorectomy); H = women who underwent hysterectomy, not combined with bilateral oophorectomy; M = age-matched male controls; N = women with natural menopause; OW = office workers, P = premenopausal (control) subjects; S = women who underwent surgical menopause. The number of subjects per group is reported between parentheses. menopausal women reduced systolic and diastolic BP and enhanced the basal but not the acetylcholine-induced nitric oxide release in fore-arm resistance arteries. The latter findings 50 are in line with the observation that in premenopausal women compared with men, the age-related endothelial dysfunction is attenuated, whereas this sex difference disappears after menopause, suggesting a protective effect of oestrogens on endothelial function. 51 In natural menopause oestrogen deprivation develops gradually. 14, 37 If the menopausal increase in SBP is brought about by a reduced arterial compliance, the arterial dysfunction may be initially functionally mediated and partially compensated for by an increased arterial diameter. 46 The elevated SBP may be difficult to detect especially in perimenopausal women, unless the slope of BP on age (Figure 1 ) or the BP changes over time (Figure 2 ) are studied. Later in menopause, the decrease in arterial compliance may become structural. The higher serum cholesterol, 52 the smaller high-density lipoprotein fraction, 52 the increased peroxidation of lipoproteins, 53 the endothelial dysfunction, 50,51 and the enhanced wall stress resulting from the intermittently functionally elevated SBP may set the stage for atherosclerotic lesions. These, in turn, could irreversibly reduce arterial distensibility and maintain SBP on a rising track. Only then the conventional and ambulatory BP could become permanently elevated. 31 In a Dutch study, 54 which accounted for age and other cardiovascular risk indicators, women with natural menopause had a 3.4 times greater risk of having atherosclerosis of the abdominal aorta than their premenopausal counterparts and women with surgical menopause a 5.5 greater risk. Systolic hypertension as a consequence of reduced arterial compliance may contribute to the enhanced cardiovascular mortality in women with an early menopause. 55 
Conclusions
The influence of menopause per se on BP remains uncertain. Recent experimental and epidemiological evidence supports the hypothesis that oestrogen deficiency may induce endothelial and vascular dysfunction and potentiate the age-related increase in SBP, possibly as a consequence of a reduced compliance of the large arteries. However, the latter hypothesis requires further investigation. Neverthe-less, there is some suggestion that oestrogen replacement treatment may reduce the incidence of stroke. 56 
